Name | Number of supported studies | Average coverage | |
---|---|---|---|
retinal cone cell | 6 studies | 46% ± 27% | |
epithelial cell | 3 studies | 30% ± 8% | |
glutamatergic neuron | 3 studies | 32% ± 12% | |
macrophage | 3 studies | 19% ± 4% | |
endothelial cell | 3 studies | 20% ± 2% | |
transit amplifying cell | 3 studies | 23% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2233.32 | 1445 / 1445 | 100% | 26.41 | 183 / 183 |
lung | 100% | 2347.76 | 578 / 578 | 100% | 18.79 | 1153 / 1155 |
intestine | 100% | 2433.56 | 966 / 966 | 100% | 22.76 | 526 / 527 |
breast | 100% | 2709.70 | 459 / 459 | 100% | 25.79 | 1115 / 1118 |
stomach | 100% | 1857.95 | 359 / 359 | 100% | 23.60 | 285 / 286 |
prostate | 100% | 2270.13 | 245 / 245 | 100% | 21.76 | 500 / 502 |
ovary | 100% | 2240.14 | 180 / 180 | 99% | 20.84 | 427 / 430 |
bladder | 100% | 2526.48 | 21 / 21 | 99% | 19.05 | 500 / 504 |
thymus | 100% | 2918.12 | 653 / 653 | 99% | 21.38 | 600 / 605 |
uterus | 100% | 2409.06 | 170 / 170 | 99% | 18.27 | 455 / 459 |
pancreas | 99% | 1312.42 | 325 / 328 | 99% | 17.01 | 177 / 178 |
skin | 100% | 2954.01 | 1809 / 1809 | 98% | 21.90 | 462 / 472 |
brain | 98% | 1319.58 | 2582 / 2642 | 100% | 17.25 | 703 / 705 |
kidney | 100% | 1602.18 | 89 / 89 | 97% | 14.70 | 876 / 901 |
liver | 100% | 1206.75 | 225 / 226 | 95% | 10.34 | 384 / 406 |
adrenal gland | 100% | 2457.88 | 258 / 258 | 93% | 12.07 | 213 / 230 |
adipose | 100% | 2523.61 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2468.45 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 24.05 | 29 / 29 |
muscle | 100% | 3674.31 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2366.93 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 19.35 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.53 | 1 / 1 |
heart | 96% | 1274.62 | 825 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 93% | 11.17 | 74 / 80 |
peripheral blood | 67% | 1490.77 | 623 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016567 | Biological process | protein ubiquitination |
GO_0035212 | Biological process | cell competition in a multicellular organism |
GO_0033151 | Biological process | V(D)J recombination |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0043687 | Biological process | post-translational protein modification |
GO_0006338 | Biological process | chromatin remodeling |
GO_0045732 | Biological process | positive regulation of protein catabolic process |
GO_0030183 | Biological process | B cell differentiation |
GO_0005654 | Cellular component | nucleoplasm |
GO_0080008 | Cellular component | Cul4-RING E3 ubiquitin ligase complex |
GO_0001650 | Cellular component | fibrillar center |
GO_0008180 | Cellular component | COP9 signalosome |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_1990756 | Molecular function | ubiquitin-like ligase-substrate adaptor activity |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0030331 | Molecular function | nuclear estrogen receptor binding |
GO_0005524 | Molecular function | ATP binding |
GO_1990244 | Molecular function | histone H2AT120 kinase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | DCAF1 |
Protein name | DDB1- and CUL4-associated factor 1 (HIV-1 Vpr-binding protein) (VprBP) (Serine/threonine-protein kinase VPRBP) (EC 2.7.11.1) (Vpr-interacting protein) |
Synonyms | KIAA0800 VPRBP RIP |
Description | FUNCTION: Acts both as a substrate recognition component of E3 ubiquitin-protein ligase complexes and as an atypical serine/threonine-protein kinase, playing key roles in various processes such as cell cycle, telomerase regulation and histone modification. Probable substrate-specific adapter of a DCX (DDB1-CUL4-X-box) E3 ubiquitin-protein ligase complex, named CUL4A-RBX1-DDB1-DCAF1/VPRBP complex, which mediates ubiquitination and proteasome-dependent degradation of proteins such as NF2. Involved in the turnover of methylated proteins: recognizes and binds methylated proteins via its chromo domain, leading to ubiquitination of target proteins by the RBX1-DDB1-DCAF1/VPRBP complex . The CUL4A-RBX1-DDB1-DCAF1/VPRBP complex is also involved in B-cell development: DCAF1 is recruited by RAG1 to ubiquitinate proteins, leading to limit error-prone repair during V(D)J recombination. Also part of the EDVP complex, an E3 ligase complex that mediates ubiquitination of proteins such as TERT, leading to TERT degradation and telomerase inhibition . Also acts as an atypical serine/threonine-protein kinase that specifically mediates phosphorylation of 'Thr-120' of histone H2A (H2AT120ph) in a nucleosomal context, thereby repressing transcription. H2AT120ph is present in the regulatory region of many tumor suppresor genes, down-regulates their transcription and is present at high level in a number of tumors . Involved in JNK-mediated apoptosis during cell competition process via its interaction with LLGL1 and LLGL2 . By acting on TET dioxygenses, essential for oocyte maintenance at the primordial follicle stage, hence essential for female fertility (By similarity). .; FUNCTION: (Microbial infection) In case of infection by HIV-1 virus, it is recruited by HIV-1 Vpr in order to hijack the CUL4A-RBX1-DDB1-DCAF1/VPRBP function leading to arrest the cell cycle in G2 phase, and also to protect the viral protein from proteasomal degradation by another E3 ubiquitin ligase. The HIV-1 Vpr protein hijacks the CUL4A-RBX1-DDB1-DCAF1/VPRBP complex to promote ubiquitination and degradation of proteins such as TERT and ZIP/ZGPAT. .; FUNCTION: (Microbial infection) In case of infection by HIV-2 virus, it is recruited by HIV-2 Vpx in order to hijack the CUL4A-RBX1-DDB1-DCAF1/VPRBP function leading to enhanced efficiency of macrophage infection and promotion of the replication of cognate primate lentiviruses in cells of monocyte/macrophage lineage. . |
Accessions | Q9Y4B6 ENST00000504652.5 [Q9Y4B6-2] ENST00000423656.5 [Q9Y4B6-1] ENST00000684031.1 [Q9Y4B6-1] |